COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,100 Articles (22,658 medRxiv, 8,442 bioRxiv)

Most recent first Previous |  Page 2893: Articles 28921-28930  | Next

Estimating the burden of SARS-CoV-2 in France
Salje, H., Tran Kiem, C., Lefrancq, N., Courtejoie, N., Bosetti, P., Paireau, J., Andronico, A., Hoze, N., Richet, J., Dubost, C.-L., Le Strat, Y., Lessler, J., Levy Bruhl, D., Fontanet, A., Opatowski, L., Boelle, P.-Y., Cauchemez, S.
10.1101/2020.04.20.20072413 — Posted: 2020-04-24
Predicting mortality attributable to SARS-CoV-2: A mechanistic score relating obesity and diabetes to COVID-19 outcomes in Mexico
Bello-Chavolla, O. Y., Bahena-Lopez, J. P., Antonio-Villa, N. E., Vargas-Vazquez, A., Gonzalez-Diaz, A., Marquez-Salinas, A., Fermin-Martinez, C. A., Naveja, J. J., Aguilar-Salinas, C. A.
10.1101/2020.04.20.20072223 — Posted: 2020-04-24 Discussion: Onsite
Prevalence and Impact of Myocardial Injury in Patients Hospitalized with COVID-19 Infection
Lala, A., Johnson, K. W., Russak, A. J., Paranjpe, I., Zhao, S., Manna, S., Solani, S., Vaid, A., Chaudhry, F., De Freitas, J. K., Fayad, Z. A., Pinney, S. P., Levin, M., Charney, A., Bagiella, E., Narula, J., Glicksberg, B. S., Nadkarni, G., Januzzi, J., Mancini, D. M., Fuster, V.
10.1101/2020.04.20.20072702 — Posted: 2020-04-24 Discussion: Onsite
A phased approach to unlocking during the COVID-19 pandemic; Lessons from trend analysis
Stedman, M., Davies, M., Anderson, S. G., Lunt, M., Verma, A., Heald, A.
10.1101/2020.04.20.20072264 — Posted: 2020-04-24
The Association of Lymphocyte count and levels of CRP, D-Dimer, and LDH with severe coronavirus disease 2019 (COVID-19): A Meta-Analysis
Ali, A., Mohamed, S., Elkhidir, I., Elbathani, M., Ibrahim, A., Elhassan, A., Salman, M., Elhassan, M., Elnil, M., Abuzied, A.
10.1101/2020.04.20.20072801 — Posted: 2020-04-24
Clinical features of coronavirus disease 2019 (COVID-19) in a cohort of patients with disability due to spinal cord injury
Gil-Agudo, A., Rodriguez-Cola, M., Jimenez-Velasco, I., Gutierrez-Henares, F., Lopez-Dolado, E., Gambarrutta-Malfatti, C., Vargas-Baquero, E.
10.1101/2020.04.20.20072918 — Posted: 2020-04-24
COVID-19 in Iran, a comprehensive investigation from exposure to treatment outcomes
Ashraf, M. A., Shokouhi, N., Shirali, E., Davari-tanha, F., Memar, O., Kamalipour, A., Azarnoush, A., Mabadi, A., Ossareh, A., Sanginabadi, M., Mokhtari Azad, T., Aghaghazvini, L., Ghaderkhani, S., Poordast, T., Pourdast, A., Nazemi, P.
10.1101/2020.04.20.20072421 — Posted: 2020-04-24 Discussion: Onsite
Prevalence of SARS-CoV-2 infection in previously undiagnosed health care workers at the onset of the U.S. COVID-19 epidemic
Barrett, E. S., Horton, D. B., Roy, J., Gennaro, M. L., Brooks, A., Tischfield, J., Greenberg, P., Andrews, T., Jagpal, S., Reilly, N., Blaser, M. J., Carson, J., Panettieri, R. A.
10.1101/2020.04.20.20072470 — Posted: 2020-04-24
Variational-LSTM Autoencoder to forecast the spread of coronavirus across the globe
Ibrahim, M. R., Haworth, J., Lipani, A., Aslam, N., Cheng, T., Christie, N.
10.1101/2020.04.20.20070938 — Posted: 2020-04-24
Accelerated hyaluronan concentration as the primary driver of morbidity and mortality in high-risk COVID-19 patients: with therapeutic introduction of an oral hyaluronan inhibitor in the prevention of "Induced Hyaluronan Storm" Syndrome
Awkal, J. A., Mong, M. A., Marik, P. E.
10.1101/2020.04.19.20071647 — Posted: 2020-04-24 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).